Transcranial direct current stimulation combined with transcranial magnetic stimulation provides safe and more effective major depressive disorder treatment.

UK System for Patient Treatment of MDD, OCD and Decreasing Anxiety*CARMARTHENSHIRE, United Kingom, Dec. 05, 2024 (GLOBE ...

Many individuals have been told that their illness is "treatment resistant." However, this only means that they haven't ...

In a recent study, transcranial magnetic stimulation was found to be more effective than switching to a new medication for ...

1. Transcranial direct current stimulation (tDCS) combined with repetitive transcranial magnetic stimulation (rTMS) had greater efficacy in reducing depressive symptoms in participants with major ...

It was approved by the FDA in 2008 to treat major depressive disorder, and it was recently approved for teens.

For the twenty-one million American adults experiencing major depressive disorder (MDD) annually, this FDA-cleared treatment ...

Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain ...

Researchers have flipped the script on the usual approach to pain relief in a new study, demonstrating that a short course of ...

Brainsway ( (BWAY) ) has provided an announcement.

The following is a summary of “A 5-day course of repetitive transcranial magnetic stimulation before pain onset ameliorates future pain and increases sensorimotor peak alpha frequency,” published in ...